What is H.C. Wainwright's price target for CLDX?

H.C. Wainwright's latest stated price target for Celldex Therapeutics Inc. (CLDX) is $64, from its action on Sep 22, 2026.

What is H.C. Wainwright's rating on CLDX?

H.C. Wainwright rates CLDX Buy, a bullish rating, as of Sep 22, 2026.

When did H.C. Wainwright last change its view on CLDX?

On Sep 22, 2026, H.C. Wainwright raises its price target to $64 from $42, keeps Buy.

Analyst firms · H.C. Wainwright · CLDX

H.C. Wainwright CLDX price target and rating history

Celldex Therapeutics Inc. (CLDX) · Health Care

H.C. Wainwright rates Celldex Therapeutics Inc. (CLDX) Buy with a $64 price target, as of its latest action on Sep 22, 2026. It has published 4 rating actions on CLDX since July 2021, including 0 upgrades and 0 downgrades. Across 3 firms with a CLDX price target in the last 12 months, the median target is $45. H.C. Wainwright's $64 is 42% above that.

Current rating: Buy
Price target: $64
Median target, all firms: $45
Actions on CLDX: 4

H.C. Wainwright price target on CLDX

H.C. Wainwright price target on CLDX, each point a stated target, July 2021 to September 2026.

Every H.C. Wainwright rating on CLDX

Sep 22, 2026
ReiterateH.C. Wainwright raises its price target to $64 from $42, keeps Buy
Sep 13, 2021
ReiterateH.C. Wainwright raises its price target to $60 from $54, keeps Buy
Aug 6, 2021
ReiterateH.C. Wainwright raises its price target to $54 from $50, keeps Buy
Jul 12, 2021
ReiterateH.C. Wainwright raises its price target to $50 from $36, keeps Buy

How other firms rate CLDX

Each firm's latest rating and stated target in the last 12 months.

Firm	Rating	Price target	Date
H.C. Wainwright	Buy	$64	Sep 22, 2026
Barclays	Overweight	$45	Apr 20, 2026
Wolfe Research	Outperform	$44	Mar 23, 2026

Questions about H.C. Wainwright and CLDX

What is H.C. Wainwright's price target for CLDX?: H.C. Wainwright's latest stated price target for Celldex Therapeutics Inc. (CLDX) is $64, from its action on Sep 22, 2026.
What is H.C. Wainwright's rating on CLDX?: H.C. Wainwright rates CLDX Buy, a bullish rating, as of Sep 22, 2026.
When did H.C. Wainwright last change its view on CLDX?: On Sep 22, 2026, H.C. Wainwright raises its price target to $64 from $42, keeps Buy.
How does H.C. Wainwright's CLDX target compare with other analysts?: Across 3 firms with a CLDX price target in the last 12 months, the median target is $45. H.C. Wainwright's $64 is 42% above that.

More CLDX rating histories

Wolfe Research3

All H.C. Wainwright ratings CLDX news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.